Skip to content
healthcare.dev

TRIESENCE

NDC 82667-800, triamcinolone acetonide, injection, suspension, from Harrow Eye, LLC.

Product NDC
82667-800
Status
Listed
Labeler
Harrow Eye, LLC
Dosage form
INJECTION, SUSPENSION
Route
OPHTHALMIC
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022048
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82667-800 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRIAMCINOLONE ACETONIDE40 mg/mL

Pharmacologic classes

Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]

Package NDCNDC-11Package
82667-800-01826670800011 BLISTER PACK in 1 CARTON (82667-800-01) / 1 VIAL, GLASS in 1 BLISTER PACK / 1 mL in 1 VIAL, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2267978c-72ad-9229-e063-6394a90a09d0
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=82667-800

Use it

Look up 82667-800 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82667-800 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82667-800. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.